𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Molecular epidemiologic studies of polycyclic aromatic hydrocarbon–DNA adducts and breast cancer

✍ Scribed by Andrew Rundle; Deliang Tang; Hanina Hibshoosh; Freya Schnabel; Amalia Kelly; Richard Levine; Jingzhi Zhou; Bruce Link; Frederica Perera

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
83 KB
Volume
39
Category
Article
ISSN
0893-6692

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Polycyclic aromatic hydrocarbon-DNA addu
Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls
✍ Shu-Yuan Chen; Li-Yu Wang; Ruth M. Lunn; Wei-Yann Tsai; Po-Huang Lee; Chue-Shue 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 421 KB

## Abstract HCC is a common cancer and HBV and AFB~1~ are well‐documented, major risk factors. Epidemiologic studies have documented that cigarette smoking also contributes to the development of HCC. PAHs are ubiquitous environmental pollutants and products of incomplete combustion. They are presen

DNA adducts in urothelial cells: Relatio
DNA adducts in urothelial cells: Relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke
✍ Paolo Vineis; Glenn Talaska; Christian Malaveille; Helmut Bartsch; Tiziana Marto 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 320 KB 👁 1 views

Markers of exposure to polycyclic aromatic hydrocarbons (urinary I -hydroxypyrene-glucuronide) and aromatic arnines (4-aminobiphenyl-hemoglobin adducts), as well as urinary mutagenicity, were measured in 47 healthy smokers and 50 nonsmokers. DNA adducts were determined by P32-postlabeling in the exf

Polycyclic aromatic hydrocarbon-inducibl
Polycyclic aromatic hydrocarbon-inducible DNA adducts: Evidence by 32P-postlabeling and use of knockout mice for Ah receptor-independent mechanisms of metabolic activation in vivo
✍ Sudha R. Kondraganti; Pedro Fernandez-Salguero; Frank J. Gonzalez; Kenneth S. Ra 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 264 KB 👁 1 views

## Abstract There is significant human exposure to polycyclic aromatic hydrocarbons (PAHs), many of which are potent carcinogens in laboratory animals and are suspected human carcinogens. The PAHs are bioactivated by cytochrome P450 (CYP)1A1/1B1 enzymes to reactive intermediates that bind to DNA, a

Expression of CYP1A1, CYP1B1 and CYP3A,
Expression of CYP1A1, CYP1B1 and CYP3A, and polycyclic aromatic hydrocarbon-DNA adduct formation in bronchoalveolar macrophages of smokers and non-smokers
✍ Ritva Piipari; Kirsti Savela; Tuula Nurminen; Janne Hukkanen; Hannu Raunio; Jukk 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 107 KB

Variability in the expression of enzymes metabolizing carcinogens derived from cigarette smoke may contribute to individual susceptibility to pulmonary carcinogenesis. This study was designed to determine the effects of smoking and 3 major cytochrome P450 (CYP) enzymes, i.e., CYP1A1, CYP1B1 and CYP3